The table below shows Bio-Rad Laboratories, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$532.20M
$455.20M
$374.90M
$194.40M
$669.46M
$584.97M
Capital expenditure
$157.60M
$165.60M
$156.70M
$112.80M
$133.75M
$108.56M
Investing cash flow
-$189.70M
-$160.20M
$20.20M
-$1.21B
-$797.38M
-$69.89M
Dividends paid
-
-
-
-
-
BIO operating cash flow (10-K history)
Bio-Rad Laboratories, Inc. reported operating cash flow of $532.20M for fiscal year 2025. That is up 16.9% from $455.20M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $216.07M (FY 2016) to $532.20M. Figures come from the company's audited annual reports as filed with the SEC.
